[an error occurred while processing this directive]|[an error occurred while processing this directive]
非小细胞肺癌患者生活质量研究现状
冉俊涛, 王静波, 王绿化
100021 北京,国家癌症中心/中国医学科学院北京协和医学院肿瘤医院放疗科
Quality of life of patients with non-small-cell lung cancer
Ran Juntao, Wang Jingbo, Wang Lvhua
Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021,China
Abstract：Along with the development of modern medical modality and health awareness, the maintenance of favorable quality of life (QoL) has become one of the most important goals for cancer survivors. Non-small-cell lung cancer (NSCLC) survivors may suffer from substantial impairment on the overall QoL due to surgical treatment, radiotherapy and chemotherapy, etc. Evaluating the effect of NSCLC treatment upon the QoL of NSCLC patients contributes to understanding and enhancing the QoL through relevant interventions, improving life-cycle surveillance and subsequently obtaining the optimal therapeutic option. In this paper, recent researches on the QoL of NSCLC patients were summarized and reviewed.
Ran Juntao,Wang Jingbo,Wang Lvhua. Quality of life of patients with non-small-cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2018, 27(9): 855-858.
[1] LeBlanc TW,Nickolich M,Rushing CN,et al. What bothers lung cancer patients the most? A prospective,longitudinal electronic patient-reported outcomes study in advanced non-small cell lung cancer[J].Support Care Cancer,2015,23(12):3455-3463.DOI:10.1007/s00520-015-2699-4. [2] Mohan A,Singh P,Singh S,et al. Quality of life in lung cancer patients:impact of baseline clinical profile and respiratory status[J].Eur J Cancer Care (Engl),2007,16(3):268-276.DOI:10.1111/j.1365-2354.2006.00741.x. [3] Iyer S,Roughley A,Rider A,et al. The symptom burden of non-small cell lung cancer in the USA:a real-world cross-sectional study[J].Support Care Cancer,2014,22(1):181-187.DOI:10.1007/s00520-013-1959-4. [4] Berger AM,Mitchell SA,Jacobsen PB,et al. Screening,evaluation,and management of cancer-related fatigue:Ready for implementation to practice?[J].CA Cancer J Clin,2015,65(3):190-211.DOI:10.3322/caac.21268. [5] Sarna L,Evangelista L,Tashkin D,et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer[J].Chest,2004,125(2):439-445. [6] Green CR,Hart-Johnson T,Loeffler DR.Cancer-related chronic pain:examining quality of life in diverse cancer survivors[J].Cancer,2011,117(9):1994-2003.DOI:10.1002/cncr.25761. [7] Dajczman E,Gordon A,Kreisman H,et al. Long-Term Postthoracotomy Pain[J].Chest,1991,99(2):270-274.DOI:10.1378/chest.99.2.270. [8] Huang J,Logue AE,Ostroff JS,et al. Comprehensive long-term care of patients with lung cancer:development of a novel thoracic survivorship program[J].Ann Thorac Surg,2014,98(3):955-961.DOI:10.1016/j.athoracsur.2014.05.020. [9] Linden W,Vodermaier A,Mackenzie R,et al. Anxiety and depression after cancer diagnosis:prevalence rates by cancer type,gender,and age[J].J Affect Disord,2012,141(2-3):343-351.DOI:10.1016/j.jad.2012.03.025. [10] Zabora J,BrintzenhofeSzoc K,Curbow B,et al. The prevalence of psychological distress by cancer site[J].Psychooncology,2001,10(1):19-28. [11] Uchitomi Y,Mikami I,Nagai K,et al. Depression and psychological distress in patients during the year after curative resection of non-small-cell lung cancer[J].J Clin Oncol,2003,21(1):69-77.DOI:10.1200/JCO.2003.12.139. [12] Sung MR,Patel MV,Djalalov S,et al. Evolution of Symptom Burden of Advanced Lung Cancer Over a Decade[J].Clin Lung Cancer,2017,18(3):274-280 e276.DOI:10.1016/j.cllc.2016.12.010. [13] Peeters L,Sibille A,Anrys B,et al. Maintenance therapy for advanced non-small-cell lung cancer:a pilot study on patients′ perceptions[J].J Thorac Oncol,2012,7(8):1291-1295.DOI:10.1097/JTO.0b013e31825879ea. [14] Bridges JF,Mohamed AF,Finnern HW,et al. Patients′ preferences for treatment outcomes for advanced non-small cell lung cancer:a conjoint analysis[J].Lung Cancer,2012,77(1):224-231.DOI:10.1016/j.lungcan.2012.01.016. [15] Wilson MK,Karakasis K,Oza AM.Outcomes and endpoints in trials of cancer treatment:the past,present,and future[J].The Lancet Oncology,2015,16(1):e32-e42.DOI:10.1016/s1470-2045(14)70375-4. [16] Damm K,Roeske N,Jacob C.Health-related quality of life questionnaires in lung cancer trials:a systematic literature review[J].Health Econ Rev,2013,3(1):15.DOI:10.1186/2191-1991-3-15. [17] Wan C,Lu Y,Tang W,et al. Development and validation of the system of quality of life instruments for cancer patients:lung cancer (QLICP-LU)[J].Lung Cancer,2008,60(1):105-112.DOI:10.1016/j.lungcan.2007.09.006. [18] 刘福安,于世英.癌症患者生活质量评估量表QLQ252的设计及质量评价[J].临床肿瘤学杂志,2005,10(3):235-239. [19] Kenny PM,King MT,Viney RC,et al. Quality of life and survival in the 2 years after surgery for non small-cell lung cancer[J].J Clin Oncol,2008,26(2):233-241.DOI:10.1200/JCO.2006.07.7230. [20] Balduyck B,Hendriks J,Lauwers P,et al. Quality of life evolution after lung cancer surgery in septuagenarians:a prospective study[J].Eur J Cardiothorac Surg,2009,35(6):1070-1075;discussion 1075.DOI:10.1016/j.ejcts.2009.01.050. [21] Ferguson MK,Parma CM,Celauro AD,et al. Quality of life and mood in older patients after major lung resection[J].Ann Thorac Surg,2009,87(4):1007-1012;discussion 1012-1003.DOI:10.1016/j.athoracsur.2008.12.084. [22] Moller A,Sartipy U.Long-term health-related quality of life following surgery for lung cancer[J].Eur J Cardiothorac Surg,2012,41(2):362-367.DOI:10.1016/j.ejcts.2011.05.055. [23] Moller A,Sartipy U.Changes in quality of life after lung surgery in old and young patients:are they similar?[J].World J Surg,2010,34(4):684-691.DOI:10.1007/s00268-010-0430-7. [24] Balduyck B,Sardari Nia P,Cogen A,et al. The effect of smoking cessation on quality of life after lung cancer surgery[J].Eur J Cardiothorac Surg,2011,40(6):1432-1437;discussion 1437-1438.DOI:10.1016/j.ejcts.2011.03.004. [25] Balduyck B,Hendriks J,Lauwers P,et al. Quality of life after lung cancer surgery:a prospective pilot study comparing bronchial sleeve lobectomy with pneumonectomy[J].J Thorac Oncol,2008,3(6):604-608.DOI:10.1097/JTO.0b013e318170fca4. [26] Bendixen M,Jorgensen OD,Kronborg C,et al. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer:a randomised controlled trial[J].Lancet Oncol,2016,17(6):836-844.DOI:10.1016/S1470-2045(16)00173-X. [27] Chang JY,Senan S,Paul MA,et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage Ⅰ non-small-cell lung cancer:a pooled analysis of two randomised trials[J].The Lancet Oncology,2015,16(6):630-637.DOI:10.1016/s1470-2045(15)70168-3. [28] Jain S,Poon I,Soliman H,et al. Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days:a comparison of acute toxicity and quality of life[J].Radiother Oncol,2013,108(2):320-325.DOI:10.1016/j.radonc.2013.06.045. [29] van der Voort van Zyp NC,Prevost JB,van der Holt B,et al. Quality of life after stereotactic radiotherapy for stage Ⅰ non-small-cell lung cancer[J].Int J Radiat Oncol Biol Phys,2010,77(1):31-37.DOI:10.1016/j.ijrobp.2009.04.080. [30] Langendijk JA,Aaronson NK,de Jong JM,et al. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer[J].J Clin Oncol,2001,19(8):2123-2133. [31] Hallqvist A,Bergman B,Nyman J.Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab—pooled results from two prospective clinical trials[J].Radiother Oncol,2012,104(1):39-44.DOI:10.1016/j.radonc.2012.05.006. [32] Strom HH,Bremnes RM,Sundstrom SH,et al. Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage Ⅲ non-small-cell lung cancer:a randomised trial by the Norwegian Lung Cancer Study Group[J].Br J Cancer,2013,109(6):1467-1475.DOI:10.1038/bjc.2013.466. [33] Movsas B,Hu C,Sloan J,et al. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer:A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial[J].JAMA Oncol,2016,2(3):359-367.DOI:10.1001/jamaoncol.2015.3969. [34] Bezjak A,Lee CW,Ding K,et al. Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer:results from a randomized trial,JBR.10[J].J Clin Oncol,2008,26(31):5052-5059.DOI:10.1200/JCO.2007.12.6094. [35] Gronberg BH,Sundstrom S,Kaasa S,et al. Influence of comorbidity on survival,toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy[J].Eur J Cancer,2010,46(12):2225-2234.DOI:10.1016/j.ejca.2010.04.009. [36] Karczmarek-Borowska B,Pelc M,Rabiej E,et al. The quality of life of non-small cell lung cancer patients treated with chemotherapy[J].Pneumonol Alergol Pol,2014,82(4):349-357.DOI:10.5603/PiAP.2014.0044. [37] Flotten O,Gronberg BH,Bremnes R,et al. Vinorelbine and gemcitabine vs. vinorelbine and carboplatin as first-line treatment of advanced NSCLC.A phase Ⅲ randomised controlled trial by the Norwegian Lung Cancer Study Group[J].Br J Cancer,2012,107(3):442-447.DOI:10.1038/bjc.2012.284. [38] Wintner LM,Giesinger JM,Zabernigg A,et al. Quality of life during chemotherapy in lung cancer patients:results across different treatment lines[J].Br J Cancer,2013,109(9):2301-2308.DOI:10.1038/bjc.2013.585. [39] Yang JC,Hirsh V,Schuler M,et al. Symptom control and quality of life in LUX-Lung 3:a phase Ⅲ study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations[J].J Clin Oncol,2013,31(27):3342-3350.DOI:10.1200/JCO.2012.46.1764. [40] Geater SL,Xu CR,Zhou C,et al. Symptom and Quality of Life Improvement in LUX-Lung 6:An Open-Label Phase Ⅲ Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer[J].J Thorac Oncol,2015,10(6):883-889.DOI:10.1097/JTO.0000000000000517. [41] Chen G,Feng J,Zhou C,et al. Quality of life (QoL) analyses from OPTIMAL (CTONG-0802),a phase Ⅲ,randomised,open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)[J].Ann Oncol,2013,24(6):1615-1622.DOI:10.1093/annonc/mdt012. [42] Brennan ME,Gormally JF,Butow P,et al. Survivorship care plans in cancer:a systematic review of care plan outcomes[J].Br J Cancer,2014,111(10):1899-1908.DOI:10.1038/bjc.2014.505. [43] Baser S,Shannon VR,Eapen GA,et al. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status[J].Chest,2006,130(6):1784-1790.DOI:10.1378/chest.130.6.1784. [44] Coups EJ,Park BJ,Feinstein MB,et al. Physical activity among lung cancer survivors:changes across the cancer trajectory and associations with quality of life[J].Cancer Epidemiol Biomarkers Prev,2009,18(2):664-672.DOI:10.1158/1055-9965.EPI-08-0589. [45] Crandall K,Maguire R,Campbell A,et al. Exercise intervention for patients surgically treated for Non-Small Cell Lung Cancer (NSCLC):a systematic review[J].Surg Oncol,2014,23(1):17-30.DOI:10.1016/j.suronc.2014.01.001. [46] Kiss NK,Krishnasamy M,Isenring EA.The effect of nutrition intervention in lung cancer patients undergoing chemotherapy and/or radiotherapy:a systematic review[J].Nutr Cancer,2014,66(1):47-56.DOI:10.1080/01635581.2014.847966. [47] Badr H,Smith CB,Goldstein NE,et al. Dyadic psychosocial intervention for advanced lung cancer patients and their family caregivers:results of a randomized pilot trial[J].Cancer,2015,121(1):150-158.DOI:10.1002/cncr.29009.
2018, Vol. 27 
